# Study of E7386 in Participants With Selected Advanced Neoplasms

> **NCT03264664** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Eisai Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Advanced Neoplasms

## Interventions

- **DRUG:** E7386

## Key facts

- **NCT ID:** NCT03264664
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-07-27
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03264664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03264664, "Study of E7386 in Participants With Selected Advanced Neoplasms". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03264664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*